Fluorescence-Based Assay for Phenotypic Characterization of Human Cytomegalovirus Polymerase Mutations Regarding Drug Susceptibility and Viral Replicative FitnessCHEVILLOTTE, Meike; SCHUBERT, Axel; MERTENS, Thomas et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 3752-3761, issn 0066-4804, 10 p.Article

Differentiation between Polymorphisms and Resistance-Associated Mutations in Human Cytomegalovirus DNA PolymeraseCHEVILLOTTE, Meike; ERSING, Ina; MERTENS, Thomas et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5004-5011, issn 0066-4804, 8 p.Article

A quick and reliable method for monitoring gene expression in actinomycetesCHEVILLOTTE, Meike; MENGES, Rainer; MUTH, Günther et al.Journal of biotechnology. 2008, Vol 135, Num 3, pp 262-265, issn 0168-1656, 4 p.Article

The Tegument Protein UL71 of Human Cytomegalovirus Is Involved in Late Envelopment and Affects Multivesicular BodiesSCHAUFLINGER, Martin; FISCHER, Daniela; SCHREIBER, Andreas et al.Journal of virology. 2011, Vol 85, Num 8, pp 3821-3832, issn 0022-538X, 12 p.Article

A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypesCHEVILLOTTE, Meike; VON EINEM, Jens; MEIER, Benjamin M et al.Antiviral research. 2010, Vol 85, Num 2, pp 318-327, issn 0166-3542, 10 p.Article

Major Tegument Protein pp65 of Human Cytomegalovirus Is Required for the Incorporation of pUL69 and pUL97 into the Virus Particle and for Viral Growth in MacrophagesCHEVILLOTTE, Meike; LANDWEHR, Sandra; LINTA, Leonhard et al.Journal of virology. 2009, Vol 83, Num 6, pp 2480-2490, issn 0022-538X, 11 p.Article